Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


29.03.2021

1 AJR Am J Roentgenol
2 Am J Clin Pathol
1 Ann Oncol
1 Ann Surg Oncol
1 Ann Thorac Surg
1 Arch Bronconeumol
1 BMC Cancer
3 Br J Cancer
4 Cancer Lett
1 Cancer Res
1 Carcinogenesis
3 Chest
4 Clin Lung Cancer
1 Eur J Cancer
2 J Cancer Res Clin Oncol
1 J Surg Oncol
7 J Thorac Cardiovasc Surg
7 Lung Cancer
3 Oncogene
3 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. FLORES EJ, Narayan AK
    Beyond the AJR: "Using prediction-models to reduce persistent racial/ethnic disparities in draft 2020 USPSTF lung-cancer screening guidelines".
    AJR Am J Roentgenol. 2021 Mar 24. doi: 10.2214/AJR.21.25877.
    PubMed        


    Am J Clin Pathol

  2. ARAKI Y, Arihiro K, Yamaguchi K, Sakamoto S, et al
    Analysis of microRNA Expression in Liquid-Based Cytology Samples May Be Useful for Primary Lung Cancer Diagnosis.
    Am J Clin Pathol. 2021 Mar 26. pii: 6189027. doi: 10.1093.
    PubMed         Abstract available

  3. BOLAND JM, Lee HE, Barr Fritcher EG, Voss JS, et al
    Molecular Genetic Landscape of Sclerosing Pneumocytomas.
    Am J Clin Pathol. 2021;155:397-404.
    PubMed         Abstract available


    Ann Oncol

  4. STINCHCOMBE TE
    EDITORIAL Lorlatinib in the treatment of anaplastic lymphoma kinase positive non-small-cell lung cancer.
    Ann Oncol. 2021 Mar 16. pii: S0923-7534(21)00876.
    PubMed        


    Ann Surg Oncol

  5. MIMAE T, Saji H, Okada M
    ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?
    Ann Surg Oncol. 2021 Mar 23. pii: 10.1245/s10434-021-09860.
    PubMed        


    Ann Thorac Surg

  6. GAUDIOSO C, Sykes A, Whalen PE, Attwood KM, et al
    Impact of a Thoracic Multidisciplinary Conference on Lung Cancer Outcomes.
    Ann Thorac Surg. 2021 Mar 17. pii: S0003-4975(21)00523.
    PubMed         Abstract available


    Arch Bronconeumol

  7. RODRIGUEZ-MARTINEZ A, Ruano-Ravina A, Torres-Duran M, Provencio M, et al
    Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study.
    Arch Bronconeumol. 2021 Feb 13. pii: S0300-2896(21)00052.
    PubMed         Abstract available


    BMC Cancer

  8. KUO CS, Tung PH, Huang AC, Wang CC, et al
    A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed.
    BMC Cancer. 2021;21:309.
    PubMed         Abstract available


    Br J Cancer

  9. SONG X, Gong J, Zhang X, Feng X, et al
    Plasma-based early screening and monitoring of EGFR mutations in NSCLC patients by a 3-color digital PCR assay.
    Br J Cancer. 2020;123:1437-1444.
    PubMed         Abstract available

  10. JIANG Y, Martin J, Alkadhimi M, Shigemori K, et al
    Olaparib increases the therapeutic index of hemithoracic irradiation compared with hemithoracic irradiation alone in a mouse lung cancer model.
    Br J Cancer. 2021 Mar 19. pii: 10.1038/s41416-021-01296.
    PubMed         Abstract available

  11. AMBROISE G, Yu TT, Zhang B, Kacal M, et al
    Systematic analysis reveals a functional role for STAMBPL1 in the epithelial-mesenchymal transition process across multiple carcinomas.
    Br J Cancer. 2020;123:1164-1177.
    PubMed         Abstract available


    Cancer Lett

  12. XIE J, Yang P, Lin HP, Li Y, et al
    Integrin alpha4 up-regulation activates the hedgehog pathway to promote arsenic and benzo[alpha]pyrene co-exposure-induced cancer stem cell-like property and tumorigenesis.
    Cancer Lett. 2020;493:143-155.
    PubMed         Abstract available

  13. YAO C, Su L, Zhang F, Zhu X, et al
    Thevebioside, the active ingredient of traditional Chinese medicine, promotes ubiquitin-mediated SRC-3 degradation to induce NSCLC cells apoptosis.
    Cancer Lett. 2020;493:167-177.
    PubMed         Abstract available

  14. CHEN D, Wu X, Chen Y, Chen C, et al
    Comment on 'Clinical significance and inflammatory landscapes of a novel recurrence associated immune signature in early-stage lung adenocarcinoma'.
    Cancer Lett. 2020;494:17.
    PubMed        

  15. SUN N, Zhang C, He J
    Response to comment on 'Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma'.
    Cancer Lett. 2020;494:5-6.
    PubMed        


    Cancer Res

  16. ANCEY PB, Contat C, Boivin G, Sabatino S, et al
    Glut1 expression in tumor-associated neutrophils promotes lung cancer growth and resistance to radiotherapy.
    Cancer Res. 2021 Mar 22. pii: 0008-5472.CAN-20-2870.
    PubMed         Abstract available


    Carcinogenesis

  17. MA YS, Shi BW, Guo JH, Liu JB, et al
    microRNA-320b suppresses HNF4G and IGF2BP2 expression to inhibit angiogenesis and tumor growth of lung cancer.
    Carcinogenesis. 2021 Mar 24. pii: 6184612. doi: 10.1093.
    PubMed         Abstract available


    Chest

  18. GIANLUCA M, Federica S, Stefano S, Eufrasia LR, et al
    FEASIBILITY AND SAFETY OF LUNG CANCER SCREENING AND PREVENTION PROGRAM DURING THE COVID-19 PANDEMIC.
    Chest. 2021 Mar 18. pii: S0012-3692(21)00503-1. doi: 10.1016/j.chest.2021.
    PubMed        

  19. SHEN J, Crothers K, Kross EK, Petersen K, et al
    Provision of Smoking Cessation Resources in the Context of in-person Shared Decision Making for Lung Cancer Screening.
    Chest. 2021 Mar 18. pii: S0012-3692(21)00493-1. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available

  20. LIANG RB, Li P, Li BT, Jin JT, et al
    Modification of Pathological T Classification for Non-small Cell Lung Cancer with Visceral Pleural Invasion: Data from 1,055 Cases of Cancers 3 cm or Less.
    Chest. 2021 Mar 18. pii: S0012-3692(21)00500-6. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available


    Clin Lung Cancer

  21. ARGIRIS A, Miao J, Cristea MC, Chen AM, et al
    A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).
    Clin Lung Cancer. 2021 Feb 19. pii: S1525-7304(21)00032.
    PubMed         Abstract available

  22. KIKUCHI Y, Nakatani Y, Yamaguchi T
    Where Is the Primary Site of the Extra-Axial Chordoma Masquerading As Lung Cancer?
    Clin Lung Cancer. 2021 Feb 24. pii: S1525-7304(21)00047.
    PubMed        

  23. BALL S, Dash A, Igid HP, Thein KZ, et al
    Extra-axial Chordoma Masquerading as Lung Cancer.
    Clin Lung Cancer. 2021 Feb 23. pii: S1525-7304(21)00048.
    PubMed        

  24. PENG L, Deng HY, Yang Y
    Lobe-specific Lymph Node Dissection for Clinical Stage IA Non-small-cell Lung Cancer: What do we know?
    Clin Lung Cancer. 2021 Feb 16. pii: S1525-7304(21)00030.
    PubMed        


    Eur J Cancer

  25. LEE K, Kim D, Yoon S, Lee DH, et al
    Exploring the resistance mechanisms of second-line osimertinib and their prognostic implications using next-generation sequencing in patients with non-small-cell lung cancer.
    Eur J Cancer. 2021;148:202-210.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  26. ZHANG G, Cao Y, Zhang J, Zhao Z, et al
    Epidermal growth factor receptor mutations in lung adenocarcinoma: associations between dual-energy spectral CT measurements and histologic results.
    J Cancer Res Clin Oncol. 2021;147:1169-1178.
    PubMed         Abstract available

  27. WEI T, Song J, Liang K, Li L, et al
    Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    J Cancer Res Clin Oncol. 2021;147:1049-1064.
    PubMed         Abstract available


    J Surg Oncol

  28. BI W, Zhao S, Wu C, Gao J, et al
    Pulmonary mucosa-associated lymphoid tissue lymphoma: CT findings and pathological basis.
    J Surg Oncol. 2021;123:1336-1344.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  29. BRIBRIESCO A
    Commentary: Winning the battle for local control without losing war for survival against malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1520-1522.
    PubMed        

  30. VARELA G
    Commentary: Extended disease, but still not the end for patients.
    J Thorac Cardiovasc Surg. 2021;161:1507-1508.
    PubMed        

  31. STILES BM
    Commentary: Think systemically, act locally.
    J Thorac Cardiovasc Surg. 2021;161:1505-1506.
    PubMed        

  32. VEERAMACHANENI NK
    Commentary: Ground-glass opacity-an unexpected silver lining.
    J Thorac Cardiovasc Surg. 2021;161:1481-1482.
    PubMed        

  33. EBRIGHT MI
    Commentary: Acute kidney injury after intrapleural cisplatin: Minimizing collateral damage.
    J Thorac Cardiovasc Surg. 2021;161:1522-1523.
    PubMed        

  34. GROTH SS, Ripley RT
    Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1519-1520.
    PubMed        

  35. YENDAMURI S
    Commentary: A picture really is worth a thousand words.
    J Thorac Cardiovasc Surg. 2021;161:1482-1483.
    PubMed        


    Lung Cancer

  36. YUN JK, Lee GD, Choi S, Kim HR, et al
    The addition of radiotherapy to adjuvant chemotherapy has a combinatorial effect in pN2 non-small cell lung cancer only with extranodal invasion or multiple N2 metastasis.
    Lung Cancer. 2021;155:94-102.
    PubMed         Abstract available

  37. ANAND K
    Cardiac dysfunction due to Osimertinib.
    Lung Cancer. 2021;153:193-194.
    PubMed        

  38. BOMMART S, Pujol JL, Coffy A, Daures JP, et al
    Authors reply to letter to the editor by Dr Degens et al.
    Lung Cancer. 2021;153:185.
    PubMed        

  39. KUNIMASA K
    A reply to "Cardiac dysfunction due to Osimertinib".
    Lung Cancer. 2021;153:195.
    PubMed        

  40. AREDO JV, Purington N, Su L, Luo SJ, et al
    Metabolomic profiling for second primary lung cancer: A pilot case-control study.
    Lung Cancer. 2021;155:61-67.
    PubMed         Abstract available

  41. GARCIA CAMPELO MR, Lin HM, Zhu Y, Perol M, et al
    Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK+non-small cell lung cancer (ALTA-1L).
    Lung Cancer. 2021;155:68-77.
    PubMed         Abstract available

  42. TAO J, Jatoi A, Crawford J, Lam WWT, et al
    Role of dietary carbohydrates on risk of lung cancer.
    Lung Cancer. 2021;155:87-93.
    PubMed         Abstract available


    Oncogene

  43. MA S, Zhang L, Ren Y, Dai W, et al
    Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer.
    Oncogene. 2021 Mar 9. pii: 10.1038/s41388-021-01734.
    PubMed         Abstract available

  44. CHENG C, Pei X, Li SW, Yang J, et al
    CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing beta-catenin.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01692.
    PubMed         Abstract available

  45. MORENO T, Monterde B, Gonzalez-Silva L, Betancor-Fernandez I, et al
    ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01748.
    PubMed         Abstract available


    Oncol Rep

  46. GAO Y, Zhang G, Liu J, Li H, et al
    Tissue-specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA-125a-5p in lung cancer.
    Oncol Rep. 2021;45.
    PubMed         Abstract available

  47. LIAO H, Liang Y, Kang L, Xiao Y, et al
    miR4543p inhibits nonsmall cell lung cancer cell proliferation and metastasis by targeting TGFB2.
    Oncol Rep. 2021;45.
    PubMed         Abstract available

  48. WANG WJ, Ouyang C, Yu B, Chen C, et al
    Role of hypoxiainducible factor2alpha in lung cancer (Review).
    Oncol Rep. 2021;45.
    PubMed         Abstract available


    PLoS One

  49. TOYODA Y, Tabuchi T, Hama H, Morishima T, et al
    Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
    PLoS One. 2020;15:e0244644.
    PubMed         Abstract available

  50. GOMI T, Hara H, Watanabe Y, Mizukami S, et al
    Improved digital chest tomosynthesis image quality by use of a projection-based dual-energy virtual monochromatic convolutional neural network with super resolution.
    PLoS One. 2020;15:e0244745.
    PubMed         Abstract available

  51. WANG L, Wang W, Zeng S, Zheng H, et al
    Construction and validation of a 6-gene nomogram discriminating lung metastasis risk of breast cancer patients.
    PLoS One. 2020;15:e0244693.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: